2019
DOI: 10.1101/680207
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Repurposing protein degradation for optogenetic modulation of protein activities

Abstract: Non-neuronal optogenetic approaches empower precise regulation of protein dynamics in live cells but often require target-specific protein engineering. To address this challenge, we developed a generalizable light modulated protein stabilization system (GLIMPSe) to control intracellular protein level independent of its functionality. We applied GLIMPSe to control two distinct classes of proteins: mitogen-activated protein kinase phosphatase 3 (MKP3), a negative regulator of the extracellular signal-regulated k… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 40 publications
(37 reference statements)
0
3
0
Order By: Relevance
“…16 Examples include a photocaged small molecule dimerizer of the auxin-inducible domain (AID) and optogenetic approaches, such as LOV2-degron fusions for optical activation of protein degradation (B-LID) 17−19 and photoactivated cleavage of appended degron domain for optical deactivation of degradation (GLIMPSe). 20 Optical control over PROTAC function has been achieved through synthetic analogs bearing photoswitchable azobenzene linkers 21,22 and light-removable caging groups. 23−25 While the technologies mentioned above offer optical control of target protein activity, these designs include certain limitations.…”
Section: ■ Introductionmentioning
confidence: 99%
“…16 Examples include a photocaged small molecule dimerizer of the auxin-inducible domain (AID) and optogenetic approaches, such as LOV2-degron fusions for optical activation of protein degradation (B-LID) 17−19 and photoactivated cleavage of appended degron domain for optical deactivation of degradation (GLIMPSe). 20 Optical control over PROTAC function has been achieved through synthetic analogs bearing photoswitchable azobenzene linkers 21,22 and light-removable caging groups. 23−25 While the technologies mentioned above offer optical control of target protein activity, these designs include certain limitations.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Although the development of these system required substantial efforts in protein engineering, this versatile strategy enables the light-dependent protein translocation in a simpler way by fusing the biofunctional domain to the LINuS or LEXY. In addition to optical control of gene expression by manipulating the localization of transcription factor [ 20 , 21 ], LINuS and LEXY systems have also been used in optogenetic regulation of cofilin-1 for controlling F-actin assembly [ 99 ], manipulating of the endogenous p53 protein levels [ 100 ], and optogenetic translocation of TEV protease for manipulating protein degradation [ 101 ].…”
Section: Lov Domain-based Optogenetic Toolsmentioning
confidence: 99%
“…Evolved LOV contains mutations to improve the photocaging of Tobacco Etch Virus (TEV) protease cleavage sites. GLIMPSe introduces these cleavage sites between the C‐terminus of POI‐eLOV Jα helices and a series of degron signals derived from Xenopus laevis that target the uncleaved fusion for degradation (Mondal et al, 2019). These degron signals can be cleaved off by TEV proteases upon their light‐triggered release from the nucleus, where they are sequestered by an NLS fused to LEXY.…”
Section: Optogenetic Strategies To Control Subcellular Structure and mentioning
confidence: 99%